LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
MCF7	Imatinib	0.04	uM	LJP6	72	hr	1389	5983	5445	1.1007	1.1009
MCF7	Crizotinib	0.04	uM	LJP5	72	hr	1389	4267	5905	0.7211	0.7069
MCF7	JW-7-24-1	0.04	uM	LJP6	72	hr	1389	3786	5445	0.6951	0.6611
MCF7	Tozasertib	0.04	uM	LJP5	72	hr	1389	1560	5905	0.2644	0.0573
MCF7	CGP60474	0.04	uM	LJP6	72	hr	1389	727	5445	0.1339	-0.2802
MCF7	PD173074	0.04	uM	LJP6	72	hr	1389	6234	5445	1.1449	1.1423
MCF7	HG-6-64-01	0.04	uM	LJP6	72	hr	1389	6450	5445	1.1889	1.1853
MCF7	Neratinib	0.04	uM	LJP5	72	hr	1389	3737	5905	0.6332	0.6068
MCF7	HG-5-113-01	0.04	uM	LJP5	72	hr	1389	5118	5905	0.8669	0.8678
MCF7	Dasatinib	0.04	uM	LJP6	72	hr	1389	1513	5445	0.2774	0.0419
MCF7	NVP-TAE684	0.04	uM	LJP6	72	hr	1389	4311	5445	0.7910	0.7744
MCF7	CGP60474	0.04	uM	LJP5	72	hr	1389	5969	5905	1.0110	1.0106
MCF7	AT-7519	0.04	uM	LJP6	72	hr	1389	5420	5445	0.9987	0.9994
MCF7	HG-5-88-01	0.04	uM	LJP6	72	hr	1389	3675	5445	0.6770	0.6408
MCF7	Seliciclib	0.04	uM	LJP5	72	hr	1389	5996	5905	1.0155	1.0149
MCF7	AZD7762	0.04	uM	LJP6	72	hr	1389	1987	5445	0.3659	0.2000
MCF7	GW843682X	0.04	uM	LJP6	72	hr	1389	4561	5445	0.8379	0.8267
MCF7	AZD8055	0.04	uM	LJP6	72	hr	1389	1577	5445	0.2898	0.0624
MCF7	Sorafenib	0.04	uM	LJP6	72	hr	1389	5186	5445	0.9513	0.9475
MCF7	CP724714	0.04	uM	LJP5	72	hr	1389	5239	5905	0.8877	0.8892
MCF7	Dasatinib	0.04	uM	LJP5	72	hr	1389	3839	5905	0.6494	0.6252
MCF7	CP466722	0.04	uM	LJP5	72	hr	1389	6297	5905	1.0662	1.0623
MCF7	Alvocidib	0.04	uM	LJP6	72	hr	1389	1631	5445	0.2990	0.0802
MCF7	KIN001-043	0.04	uM	LJP6	72	hr	1389	5537	5445	1.0171	1.0169
MCF7	BMS345541	0.04	uM	LJP6	72	hr	1389	5438	5445	1.0020	1.0029

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)